Table of Content

1 Antiandrogen Monotherapy Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years

2 Antiandrogen Monotherapy Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer

3 Antiandrogen Monotherapy Market Forces
3.1 Global Antiandrogen Monotherapy Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment

4 Antiandrogen Monotherapy Market - By Geography
4.1 Global Antiandrogen Monotherapy Market Value and Market Share by Regions
4.1.1 Global Antiandrogen Monotherapy Value ($) by Region (2015-2020)
4.1.2 Global Antiandrogen Monotherapy Value Market Share by Regions (2015-2020)
4.2 Global Antiandrogen Monotherapy Market Production and Market Share by Major Countries
4.2.1 Global Antiandrogen Monotherapy Production by Major Countries (2015-2020)
4.2.2 Global Antiandrogen Monotherapy Production Market Share by Major Countries (2015-2020)
4.3 Global Antiandrogen Monotherapy Market Consumption and Market Share by Regions
4.3.1 Global Antiandrogen Monotherapy Consumption by Regions (2015-2020)
4.3.2 Global Antiandrogen Monotherapy Consumption Market Share by Regions (2015-2020)

5 Antiandrogen Monotherapy Market - By Trade Statistics
5.1 Global Antiandrogen Monotherapy Export and Import
5.2 United States Antiandrogen Monotherapy Export and Import (2015-2020)
5.3 Europe Antiandrogen Monotherapy Export and Import (2015-2020)
5.4 China Antiandrogen Monotherapy Export and Import (2015-2020)
5.5 Japan Antiandrogen Monotherapy Export and Import (2015-2020)
5.6 India Antiandrogen Monotherapy Export and Import (2015-2020)
5.7 ...

6 Antiandrogen Monotherapy Market - By Type
6.1 Global Antiandrogen Monotherapy Production and Market Share by Types (2015-2020)
6.1.1 Global Antiandrogen Monotherapy Production by Types (2015-2020)
6.1.2 Global Antiandrogen Monotherapy Production Market Share by Types (2015-2020)
6.2 Global Antiandrogen Monotherapy Value and Market Share by Types (2015-2020)
6.2.1 Global Antiandrogen Monotherapy Value by Types (2015-2020)
6.2.2 Global Antiandrogen Monotherapy Value Market Share by Types (2015-2020)
6.3 Global Antiandrogen Monotherapy Production, Price and Growth Rate of Steroidal (2015-2020)
6.4 Global Antiandrogen Monotherapy Production, Price and Growth Rate of Nonsteroidal (2015-2020)

7 Antiandrogen Monotherapy Market - By Application
7.1 Global Antiandrogen Monotherapy Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Antiandrogen Monotherapy Consumption by Applications (2015-2020)
7.1.2 Global Antiandrogen Monotherapy Consumption Market Share by Applications (2015-2020)
7.2 Global Antiandrogen Monotherapy Consumption and Growth Rate of Prostate Cancer (2015-2020)
7.3 Global Antiandrogen Monotherapy Consumption and Growth Rate of Benign Prostatic Hyperplasia (2015-2020)
7.4 Global Antiandrogen Monotherapy Consumption and Growth Rate of Hirsutism (2015-2020)
7.5 Global Antiandrogen Monotherapy Consumption and Growth Rate of Hyperandrogenism (2015-2020)
7.6 Global Antiandrogen Monotherapy Consumption and Growth Rate of Others (2015-2020)

8 North America Antiandrogen Monotherapy Market
8.1 North America Antiandrogen Monotherapy Market Size
8.2 United States Antiandrogen Monotherapy Market Size
8.3 Canada Antiandrogen Monotherapy Market Size
8.4 Mexico Antiandrogen Monotherapy Market Size
8.5 The Influence of COVID-19 on North America Market

9 Europe Antiandrogen Monotherapy Market Analysis
9.1 Europe Antiandrogen Monotherapy Market Size
9.2 Germany Antiandrogen Monotherapy Market Size
9.3 United Kingdom Antiandrogen Monotherapy Market Size
9.4 France Antiandrogen Monotherapy Market Size
9.5 Italy Antiandrogen Monotherapy Market Size
9.6 Spain Antiandrogen Monotherapy Market Size
9.7 The Influence of COVID-19 on Europe Market

10 Asia-Pacific Antiandrogen Monotherapy Market Analysis
10.1 Asia-Pacific Antiandrogen Monotherapy Market Size
10.2 China Antiandrogen Monotherapy Market Size
10.3 Japan Antiandrogen Monotherapy Market Size
10.4 South Korea Antiandrogen Monotherapy Market Size
10.5 Southeast Asia Antiandrogen Monotherapy Market Size
10.6 India Antiandrogen Monotherapy Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market

11 Middle East and Africa Antiandrogen Monotherapy Market Analysis
11.1 Middle East and Africa Antiandrogen Monotherapy Market Size
11.2 Saudi Arabia Antiandrogen Monotherapy Market Size
11.3 UAE Antiandrogen Monotherapy Market Size
11.4 South Africa Antiandrogen Monotherapy Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market

12 South America Antiandrogen Monotherapy Market Analysis
12.1 South America Antiandrogen Monotherapy Market Size
12.2 Brazil Antiandrogen Monotherapy Market Size
12.3 The Influence of COVID-19 on South America Market

13 Company Profiles
13.1 Astellas Pharma Inc.
13.1.1 Astellas Pharma Inc. Basic Information
13.1.2 Astellas Pharma Inc. Product Profiles, Application and Specification
13.1.3 Astellas Pharma Inc. Antiandrogen Monotherapy Market Performance (2015-2020)
13.2 Genentech Inc.
13.2.1 Genentech Inc. Basic Information
13.2.2 Genentech Inc. Product Profiles, Application and Specification
13.2.3 Genentech Inc. Antiandrogen Monotherapy Market Performance (2015-2020)
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Basic Information
13.3.2 Abbott Laboratories Product Profiles, Application and Specification
13.3.3 Abbott Laboratories Antiandrogen Monotherapy Market Performance (2015-2020)
13.4 Takeda Pharmaceutical Company Limited
13.4.1 Takeda Pharmaceutical Company Limited Basic Information
13.4.2 Takeda Pharmaceutical Company Limited Product Profiles, Application and Specification
13.4.3 Takeda Pharmaceutical Company Limited Antiandrogen Monotherapy Market Performance (2015-2020)
13.5 Amgen Inc
13.5.1 Amgen Inc Basic Information
13.5.2 Amgen Inc Product Profiles, Application and Specification
13.5.3 Amgen Inc Antiandrogen Monotherapy Market Performance (2015-2020)
13.6 Sanofi SA
13.6.1 Sanofi SA Basic Information
13.6.2 Sanofi SA Product Profiles, Application and Specification
13.6.3 Sanofi SA Antiandrogen Monotherapy Market Performance (2015-2020)
13.7 OSI Pharmaceuticals, Inc.
13.7.1 OSI Pharmaceuticals, Inc. Basic Information
13.7.2 OSI Pharmaceuticals, Inc. Product Profiles, Application and Specification
13.7.3 OSI Pharmaceuticals, Inc. Antiandrogen Monotherapy Market Performance (2015-2020)
13.8 Novartis AG
13.8.1 Novartis AG Basic Information
13.8.2 Novartis AG Product Profiles, Application and Specification
13.8.3 Novartis AG Antiandrogen Monotherapy Market Performance (2015-2020)
13.9 ANI Pharmaceuticals, Inc.
13.9.1 ANI Pharmaceuticals, Inc. Basic Information
13.9.2 ANI Pharmaceuticals, Inc. Product Profiles, Application and Specification
13.9.3 ANI Pharmaceuticals, Inc. Antiandrogen Monotherapy Market Performance (2015-2020)
13.10 GlaxoSmithKline Plc
13.10.1 GlaxoSmithKline Plc Basic Information
13.10.2 GlaxoSmithKline Plc Product Profiles, Application and Specification
13.10.3 GlaxoSmithKline Plc Antiandrogen Monotherapy Market Performance (2015-2020)
13.11 Progenics Pharmaceuticals, Inc.
13.11.1 Progenics Pharmaceuticals, Inc. Basic Information
13.11.2 Progenics Pharmaceuticals, Inc. Product Profiles, Application and Specification
13.11.3 Progenics Pharmaceuticals, Inc. Antiandrogen Monotherapy Market Performance (2015-2020)
13.12 Pfizer Inc.
13.12.1 Pfizer Inc. Basic Information
13.12.2 Pfizer Inc. Product Profiles, Application and Specification
13.12.3 Pfizer Inc. Antiandrogen Monotherapy Market Performance (2015-2020)
13.13 Bristol-Myers Squibb Company
13.13.1 Bristol-Myers Squibb Company Basic Information
13.13.2 Bristol-Myers Squibb Company Product Profiles, Application and Specification
13.13.3 Bristol-Myers Squibb Company Antiandrogen Monotherapy Market Performance (2015-2020)
13.14 AstraZeneca Plc
13.14.1 AstraZeneca Plc Basic Information
13.14.2 AstraZeneca Plc Product Profiles, Application and Specification
13.14.3 AstraZeneca Plc Antiandrogen Monotherapy Market Performance (2015-2020)
13.15 F. Hoffmann-La Roche Ltd.
13.15.1 F. Hoffmann-La Roche Ltd. Basic Information
13.15.2 F. Hoffmann-La Roche Ltd. Product Profiles, Application and Specification
13.15.3 F. Hoffmann-La Roche Ltd. Antiandrogen Monotherapy Market Performance (2015-2020)
13.16 ALZA Corporation
13.16.1 ALZA Corporation Basic Information
13.16.2 ALZA Corporation Product Profiles, Application and Specification
13.16.3 ALZA Corporation Antiandrogen Monotherapy Market Performance (2015-2020)

14 Market Forecast - By Regions
14.1 North America Antiandrogen Monotherapy Market Forecast (2020-2025)
14.2 Europe Antiandrogen Monotherapy Market Forecast (2020-2025)
14.3 Asia-Pacific Antiandrogen Monotherapy Market Forecast (2020-2025)
14.4 Middle East and Africa Antiandrogen Monotherapy Market Forecast (2020-2025)
14.5 South America Antiandrogen Monotherapy Market Forecast (2020-2025)

15 Market Forecast - By Type and Applications
15.1 Global Antiandrogen Monotherapy Market Forecast by Types (2020-2025)
15.1.1 Global Antiandrogen Monotherapy Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Antiandrogen Monotherapy Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Antiandrogen Monotherapy Market Forecast by Applications (2020-2025)